Latest Asx Market News

Page 14 of 15
VanEck Investments Limited has released a replacement Product Disclosure Statement for its VanEck Bentham Global Capital Securities Active ETF (ASX, GCAP), outlining an actively managed strategy focused on global subordinated debt securities with income and diversification benefits.
Claire Turing
Claire Turing
10 June 2025
Ridley Corporation has successfully closed its retail entitlement offer, raising $26 million as part of a $125 million capital raise to fund its $300 million acquisition of Incitec Pivot’s fertiliser distribution business.
Ada Torres
Ada Torres
4 June 2025
Victor Group Holdings has requested a voluntary suspension of its shares starting June 2, pending a significant acquisition announcement expected by June 5.
Victor Sage
Victor Sage
30 May 2025
Fintech Chain Limited has applied to delist from the ASX, citing low valuation, poor liquidity, and high costs, aiming to unlock growth capital in China and the US.
Claire Turing
Claire Turing
23 May 2025
The Takeovers Panel has declined to investigate applications challenging Pact Group Holdings’ proposed delisting, signaling regulatory acceptance of the move. The decision clarifies the Panel’s jurisdiction and leaves the delisting process on track.
Victor Sage
Victor Sage
22 May 2025
Mayne Pharma has clarified why it did not disclose an FDA Untitled Letter to the market despite sharing it with its scheme bidder, reaffirming compliance with ASX rules amid recent share price volatility.
Victor Sage
Victor Sage
22 May 2025
Island Pharmaceuticals has raised $3.6 million through a strategic share placement to advance its lead antiviral drug ISLA-101’s clinical development and broaden its asset portfolio ahead of pivotal Phase 2a/b trial results.
Ada Torres
Ada Torres
21 May 2025
Tivan Limited’s shares have been suspended at the company’s request pending a major joint venture announcement and its response to an ASX compliance query.
Maxwell Dee
Maxwell Dee
7 May 2025
Dimerix has received a US$30 million upfront payment from Amicus Therapeutics for exclusive US rights to DMX-200, a promising kidney disease therapy. The deal positions Dimerix for up to US$560 million in further milestones plus royalties, underpinning its global licensing strategy.
Ada Torres
Ada Torres
6 May 2025
Enlitic Inc. has been reinstated to trading on the ASX following its announcement of a new equity raise, signaling renewed investor interest in the health technology firm.
Sophie Babbage
Sophie Babbage
5 May 2025
Tigers Realm Coal’s planned divestment of its Russian subsidiaries has hit significant regulatory roadblocks, resulting in a reduced sale price, increased exit tax, and suspension from ASX trading.
Maxwell Dee
Maxwell Dee
29 Apr 2025
Sequoia Financial Group will release its half-year FY25 financial results on 27 February 2025, accompanied by an investor webinar hosted by its CEO and CFO.
Claire Turing
Claire Turing
18 Feb 2025

Browse the archive

Full archive